Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medic...
Canopy Growth surged intraday, rising approximately 9.1% to $1.035 as of ET 10:03, driven by post-earnings digestion of revenue beat and cost-control progress. Q4 FY2026 revenue of $51.1M was up 12.6% YoY, and while net loss widened to $112.8M, EPS loss narrowed 50.72% to -$0.293, with operating loss of only $12.6M signaling improving operating leverage. The stock rallied from a pre-market low of $0.9415 (ET 05:38) to an intraday high of $1.05, breaking above the 20-day MA ($0.98), yet remains 56.51% below the 52-week high of $2.38 and below the 60-day MA ($1.063), with a YTD decline of 13.03%. However, the disclosure of a material weakness in financial controls raised ongoing reporting and capital-raising risks, which could temper further upside.
08:40 ETCanopy Expands Retail Footprint With Nationwide Ulta Beauty Launch, Bringing Healthy Home Wellness To More Consumers
Q1 2026 Earnings Flag Margin Pressures Across Niche Sectors
Toyota's USD 3.6B Expansion and Oil Sector Buybacks Highlight Capital Shifts Beyond Big Tech
Is Canopy Growth stock finally worth buying after losing 99% of its value?
Could Canopy Growth stock deliver a 4X gain? 1 analyst thinks so.
Canopy Gwth Q4 2026 Earnings Call Transcript